ICU Medical CEO Vivek Jain sells shares worth 1.95 million
ICUI Stock | USD 165.59 0.60 0.36% |
Under 71% of ICU Medical's investor base is looking to short. The analysis of overall sentiment of trading ICU Medical stock suggests that many investors are alarmed at this time. ICU Medical's investing sentiment shows overall attitude of investors towards ICU Medical.
ICU |
ICU Medical CEO Vivek Jain sells shares worth 1.95 million
Read at investing.com
ICU Medical Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards ICU Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ICU Medical Fundamental Analysis
We analyze ICU Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICU Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICU Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
ICU Medical is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
ICU Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ICU Medical stock to make a market-neutral strategy. Peer analysis of ICU Medical could also be used in its relative valuation, which is a method of valuing ICU Medical by comparing valuation metrics with similar companies.
Peers
ICU Medical Related Equities
ATR | AptarGroup | 0.82 | ||||
ANGO | AngioDynamics | 0.77 | ||||
XRAY | Dentsply Sirona | 0.1 | ||||
HOLX | Hologic | 0.58 | ||||
MMSI | Merit Medical | 0.73 | ||||
NVST | Envista Holdings | 1.07 | ||||
HAE | Haemonetics | 1.25 | ||||
ATRC | AtriCure | 1.56 | ||||
COO | Cooper Companies, | 2.58 | ||||
AKYA | Akoya Biosciences | 4.71 |
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |